Ambea AB (publ) (LON: 0RNX)
London
· Delayed Price · Currency is GBP · Price in SEK
50.29
0.00 (0.00%)
Jul 21, 2022, 5:23 PM BST
Ambea AB Revenue
Ambea AB had revenue of 3.56B SEK in the quarter ending September 30, 2024, with 5.96% growth. This brings the company's revenue in the last twelve months to 13.97B, up 6.42% year-over-year. In the year 2023, Ambea AB had annual revenue of 13.31B with 5.36% growth.
Revenue (ttm)
13.97B SEK
Revenue Growth
+6.42%
P/S Ratio
n/a
Revenue / Employee
402.02K SEK
Employees
34,747
Market Cap
576.04M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 13.31B | 677.00M | 5.36% |
Dec 31, 2022 | 12.64B | 1.16B | 10.08% |
Dec 31, 2021 | 11.48B | 395.00M | 3.56% |
Dec 31, 2020 | 11.08B | 43.00M | 0.39% |
Dec 31, 2019 | 11.04B | 4.96B | 81.70% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |